Tolmetin-d3

Tolmetin-d3 is the deuterium labeled Tolmetin. Tolmetin is an orally active and potent COX inhibitor with IC50s of 0.35 μM and 0.82 μM human COX-1 and COX-2, respectively. Tolmetin is a non-steroidal anti-inflammatory drug (NSAID) [1][2].

1184998-16-0

12352005

COX; Isotope-Labeled Compounds

Immunology/Inflammation; Others

COVID-19-immunoregulation

Cancer; Inflammation/Immunology

10 mM in DMSO

C(=O)(C=1N(C([2H])([2H])[2H])C(CC(O)=O)=CC1)C2=CC=C(C)C=C2

C15H12D3NO3

260.30

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]T D Warner, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999 Jun 22;96 (13) :7563-8.|[3]DADAŞ, Yakup, et al. Synthesis and anticancer activity of some novel tolmetin thiosemicarbazides. Marmara Pharmaceutical Journal 19 (3) • April 2015|[4]Etcheverry SB, et al. Three new vanadyl (IV) complexes with non-steroidal anti-inflammatory drugs (Ibuprofen, Naproxen and Tolmetin) . Bioactivity on osteoblast-like cells in culture. J Inorg Biochem. 2002 Jan 1;88 (1) :94-100.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-B1799S/

Isotope-Labeled Compounds

No Development Reported